NM_001127222.2:c.4896C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001127222.2(CACNA1A):c.4896C>T(p.Phe1632Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000046   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.000028   (  0   hom.  ) 
Consequence
 CACNA1A
NM_001127222.2 synonymous
NM_001127222.2 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.92  
Publications
1 publications found 
Genes affected
 CACNA1A  (HGNC:1388):  (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016] 
CACNA1A Gene-Disease associations (from GenCC):
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31). 
BP6
Variant 19-13245236-G-A is Benign according to our data. Variant chr19-13245236-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 476262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=1.92 with no splicing effect.
BS2
High AC in GnomAd4 at 7 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1A | ENST00000360228.11 | c.4896C>T | p.Phe1632Phe | synonymous_variant | Exon 31 of 47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
| CACNA1A | ENST00000638029.1 | c.4908C>T | p.Phe1636Phe | synonymous_variant | Exon 31 of 48 | 5 | ENSP00000489829.1 | |||
| CACNA1A | ENST00000573710.7 | c.4902C>T | p.Phe1634Phe | synonymous_variant | Exon 31 of 47 | 5 | ENSP00000460092.3 | |||
| CACNA1A | ENST00000635727.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 47 | 5 | ENSP00000490001.1 | |||
| CACNA1A | ENST00000637769.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 47 | 1 | ENSP00000489778.1 | |||
| CACNA1A | ENST00000636012.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 46 | 5 | ENSP00000490223.1 | |||
| CACNA1A | ENST00000637736.1 | c.4758C>T | p.Phe1586Phe | synonymous_variant | Exon 30 of 46 | 5 | ENSP00000489861.1 | |||
| CACNA1A | ENST00000636389.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 47 | 5 | ENSP00000489992.1 | |||
| CACNA1A | ENST00000637432.1 | c.4908C>T | p.Phe1636Phe | synonymous_variant | Exon 31 of 48 | 5 | ENSP00000490617.1 | |||
| CACNA1A | ENST00000636549.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 48 | 5 | ENSP00000490578.1 | |||
| CACNA1A | ENST00000637927.1 | c.4902C>T | p.Phe1634Phe | synonymous_variant | Exon 31 of 47 | 5 | ENSP00000489715.1 | |||
| CACNA1A | ENST00000635895.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 47 | 5 | ENSP00000490323.1 | |||
| CACNA1A | ENST00000638009.2 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 47 | 1 | ENSP00000489913.1 | |||
| CACNA1A | ENST00000637276.1 | c.4899C>T | p.Phe1633Phe | synonymous_variant | Exon 31 of 46 | 5 | ENSP00000489777.1 | |||
| CACNA1A | ENST00000636768.2 | n.4899C>T | non_coding_transcript_exon_variant | Exon 31 of 45 | 5 | ENSP00000490190.2 | ||||
| CACNA1A | ENST00000713789.1 | n.4896C>T | non_coding_transcript_exon_variant | Exon 31 of 47 | ENSP00000519091.1 | 
Frequencies
GnomAD3 genomes  0.0000460  AC: 7AN: 152222Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
7
AN: 
152222
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000441  AC: 11AN: 249232 AF XY:  0.0000370   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
11
AN: 
249232
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000281  AC: 41AN: 1461590Hom.:  0  Cov.: 31 AF XY:  0.0000330  AC XY: 24AN XY: 727086 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
41
AN: 
1461590
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
24
AN XY: 
727086
show subpopulations 
African (AFR) 
 AF: 
AC: 
7
AN: 
33480
American (AMR) 
 AF: 
AC: 
2
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86252
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53398
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
31
AN: 
1111764
Other (OTH) 
 AF: 
AC: 
0
AN: 
60370
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.454 
Heterozygous variant carriers
 0 
 2 
 4 
 5 
 7 
 9 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000460  AC: 7AN: 152222Hom.:  0  Cov.: 33 AF XY:  0.0000403  AC XY: 3AN XY: 74358 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
7
AN: 
152222
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
3
AN XY: 
74358
show subpopulations 
African (AFR) 
 AF: 
AC: 
5
AN: 
41456
American (AMR) 
 AF: 
AC: 
0
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68044
Other (OTH) 
 AF: 
AC: 
0
AN: 
2094
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.561 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42    Benign:1 
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Jan 30, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.